John D. Scott wins ASPET Julius Axelrod Award

ASPET is pleased to award Dr. John D. Scott, PhD from the University of Washington, the 2024 Julius Axelrod Award in Pharmacology. The Axelrod Award was established in 1991 to honor the memory of the eminent American pharmacologist who shaped the fields of neuroscience, drug metabolism, and biochemistry and who served as a mentor for numerous eminent pharmacologists around the world.

Dr. Scott is receiving this award in recognition of his outstanding contributions to our understanding of intracellular communication networks that promote specific signal transduction.

John Scott is a world leader in studies of cell signaling and an academic leader in pharmacology. He discovered the family of A-Kinase Anchoring Proteins and showed how they organize cell-signaling pathways in time and space at the molecular and structural levels. He is Professor and Chair of Pharmacology and Edwin Krebs-Hilma Speights Professor of Cell Signaling Cancer Biology at the University of Washington. A native of Scotland, he received his B.Sc. at Heriot-Watt University and his PhD in Biochemistry at the University of Aberdeen. He was a postdoctoral fellow with Nobel Laureates Edwin Krebs and Edmund Fischer at the University of Washington and Assistant Professor of Physiology & Biophysics at the University of California/Irvine. He joined the Vollum Institute of Oregon Health & Science University in 1990 and was appointed Senior Scientist and Investigator of the Howard Hughes Medical Institute in 1997. He moved to the University of Washington in 2008. Dr Scott is a fellow of the Royal Society London, a fellow of the Royal Society of Edinburgh, and a 2020 ASPET fellow.  Dr Scott has been a member of ASPET since 1997.

The award will be presented at the Awards Lunch on May 19, 2024, during the ASPET 2024 Annual Meeting in Arlington, Va.